Osteotec entered into an exclusive agreement to distribute Novastep’s foot and ankle surgical solutions across the U.K., Ireland and Nordic regions, to address condition, from trauma to pathological and congenital deformities.
The agent agreement, effective January 1, 2025, is expected to significantly increase sales and revenue and accelerate growth. Novastep is an Enovis company, following its acquisition in 2023.
The collaboration leverages both companies’ expertise and shared values of advancement, precision and commitment to improving patient care. The two organizations look forward to combining their knowledge and technologies to maximize marketing opportunities, increase productivity and improve healthcare outcomes.
Osteotec entered into an exclusive agreement to distribute Novastep's foot and ankle surgical solutions across the U.K., Ireland and Nordic regions, to address condition, from trauma to pathological and congenital deformities.
The agent agreement, effective January 1, 2025, is expected to significantly increase sales and revenue and accelerate...
Osteotec entered into an exclusive agreement to distribute Novastep’s foot and ankle surgical solutions across the U.K., Ireland and Nordic regions, to address condition, from trauma to pathological and congenital deformities.
The agent agreement, effective January 1, 2025, is expected to significantly increase sales and revenue and accelerate growth. Novastep is an Enovis company, following its acquisition in 2023.
The collaboration leverages both companies’ expertise and shared values of advancement, precision and commitment to improving patient care. The two organizations look forward to combining their knowledge and technologies to maximize marketing opportunities, increase productivity and improve healthcare outcomes.
Copy to clipboard 
